Market Overview

The Global In Vitro Diagnostics (IVD) Market was valued at USD 97,478.3 million in 2023 and is expected to reach USD 139,688.8 million by 2031 while growing at a CAGR of 4.6% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global in vitro diagnostics (IVD) market growth. In Vitro Diagnostics (IVD) encompasses medical devices, reagents, and systems designed for analyzing specimens like blood, urine, tissue samples, and other bodily fluids outside the body, commonly conducted in laboratory settings. They play a pivotal role in diagnosing, monitoring, and managing a range of diseases and conditions.

The rising prevalence of chronic diseases and the growing geriatric population are propelling the in vitro diagnostics (IVD) market forward. Nevertheless, regulatory challenges, compliance burdens, and the complexity of healthcare systems could hinder market growth.

Furthermore, the global in vitro diagnostics (IVD) industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Test Type Analysis

The Global In Vitro Diagnostics (IVD) Market is segmented among Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types, based on Test Type. In 2023, Molecular Diagnostics accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product Analysis

The Global In Vitro Diagnostics (IVD) Market is segmented among Reagents & Kits, Instruments, and Software, based on Product. In 2023, Reagents & Kits accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global In Vitro Diagnostics (IVD) Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Biomerieux SA, Danaher Corporation, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Abbott Laboratories, Arkray Inc., Sysmex Corporation, Siemens Healthcare GmbH, and  Thermo Fischer Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global In Vitro Diagnostics (IVD) Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global In Vitro Diagnostics (IVD) Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global In Vitro Diagnostics (IVD) Market Segmentation, By Test Type

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By Test Type

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By Test Type

• Global In Vitro Diagnostics (IVD) Market Trends, By Test Type

o Clinical Chemistry

o Molecular Diagnostics

o Immuno Diagnostics

o Hematology

o Other Test Types

6. Global In Vitro Diagnostics (IVD) Market Segmentation, By Product

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By Product

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By Product

• Global In Vitro Diagnostics (IVD) Market Trends, By Product

o Reagents & Kits

o Instruments

o Software and Services

7. Global In Vitro Diagnostics (IVD) Market Segmentation, By Usability

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By Usability

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By Usability

• Global In Vitro Diagnostics (IVD) Market Trends, By Usability

o Disposable IVD Devices

o Reusable IVD Devices

8. Global In Vitro Diagnostics (IVD) Market Segmentation, By Application

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By Application

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By Application

• Global In Vitro Diagnostics (IVD) Market Trends, By Application

o Infectious Disease

o Diabetes

o Cancer/Oncology

o Cardiology

o Autoimmune Disease

o Nephrology

o Other Applications

9. Global In Vitro Diagnostics (IVD) Market Segmentation, By End Users

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By End Users

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By End Users

• Global In Vitro Diagnostics (IVD) Market Trends, By End Users

o Diagnostic Laboratories

o Hospitals and Clinics

o Other End Users

10. Global In Vitro Diagnostics (IVD) Market Segmentation, By Region

• Global In Vitro Diagnostics (IVD) Market Share Analysis, By Region

• Global In Vitro Diagnostics (IVD) Market Growth Analysis, By Region

• Global In Vitro Diagnostics (IVD) Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

11. Competitive Landscape

• Biomerieux SA*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Danaher Corporation

• F. Hoffmann-La Roche Ltd

• Becton, Dickinson and Company

• Bio-Rad Laboratories Inc.

• Abbott Laboratories

• Arkray Inc.

• Sysmex Corporation

• Siemens Healthcare GmbH

• Thermo Fischer Scientific Inc.  

*Similar analysis will be provided for each company listed above.